What is Lifecycle Biotechnologies?
Lifecycle Biotechnologies is a distinguished entity in the life science industry, boasting over 40 years of experience in supplying critical products for the advancement of medical solutions. The company specializes in innovative offerings such as the HELIX Oscillating Biomixer, CHEM+NECT, and CHEM+POUR, which are integral to bioprocessing, molecular diagnostics, and cellular agriculture applications. Serving a broad spectrum of clients including biopharmaceutical firms, tissue banks, and research institutions, Lifecycle Biotechnologies upholds stringent quality standards, evidenced by its ISO 13485:2016 and ISO 9001:2015 certifications. Their commitment extends to meeting bespoke partner requirements with unwavering product reliability and customer support.
How much funding has Lifecycle Biotechnologies raised?
Lifecycle Biotechnologies has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Lifecycle Biotechnologies?
With a substantial history and a recent strategic investment, Lifecycle Biotechnologies is well-positioned for continued expansion and innovation. The company's focus on high-quality manufacturing and diverse product applications suggests a trajectory aimed at further solidifying its market share in bioprocessing and diagnostics. Future endeavors are likely to involve leveraging this capital to enhance product development, expand market reach, and potentially explore new therapeutic areas or technological integrations. The company's established certifications and long-standing presence indicate a robust foundation for sustained growth and a commitment to advancing life-saving medical products.
See full Lifecycle Biotechnologies company page
